Data on the long-term efficacy and safety of abacavir/lamivudine (ABC/3TC) and nevirapine (NVP) are scarce. This combination has the advantage of simplifying treatment and improving long-term tolerance. The aim of this study was to compare the rate of any discontinuation of antiretroviral (ARV) regimen because of virologic failure (VF), and/or...
-
September 2016 (v1)Journal articleUploaded on: December 4, 2022
-
2017 (v1)Journal article
Failure of CD4 response (CD4 >500/mm(3)) was associated with age ≥40 years at baseline (P < 0.001), CD4 cell counts ≤500/mm(3) at month 4 (P = 0.016) or month 12 (P < 0.001) and ≥3 months of cART interruption (P = 0.016). Factors associated with failure to achieve complete immunological response (CD4 >500/mm(3) and CD4:CD8 ratio >1) were...
Uploaded on: February 28, 2023 -
November 2016 (v1)Journal article
OBJECTIVE: We assessed the virological efficacy of a 6 month maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy combining tenofovir disoproxil fumarate/emtricitabine with maraviroc/raltegravir. METHODS: HIV-1-infected naive patients were enrolled in an open label, single-arm, Phase 2 trial. All patients...
Uploaded on: December 4, 2022 -
September 3, 2021 (v1)Journal article
Background: An increased risk of cardiovascular disease (CVD) was reported in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), without identifying factors associated with atherosclerotic CVD (ASCVD) events.Methods: HIV-HCV coinfected patients were enrolled in the Agence Nationale de Recherches sur le Sida...
Uploaded on: December 4, 2022